Your partner in drug discovery  

We are leading experts in customized assay development, screening and target/hit validation using fluorescence cross-correlation spectroscopy (FCCS). 
Our partners benefit from:
  • Fast assay development time
  • Physiological measurement conditions
  • A comprehensive readout

We recently published with our customer Merck KGaA the use of FCCS to support the identification of Methionine Aminopeptidase-2 (MetAP-2) inhibitor M8891.

See our new publication on the quantifiaction of target occupancy in tissue:

Check out our new GPCR-ligand interaction assay!